Hematopoietic Stem Cells Transplantation Market Players:
- Lonza Group Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Escape Therapeutics, Inc.
- Regen BioPharma, Inc.
- ThermoGenesis Holdings, Inc.
- CSG-BIO Company, Inc. (CellSave)
- CBR Systems, Inc.
- Pluristem Inc.
- Global Cord Blood Corporation
- ViaCord, LLC
- Cynata Therapeutics Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of hematopoietic stem cells transplantation is evaluated at USD 3.83 billion.
The global hematopoietic stem cells transplantation market size exceeded USD 3.47 billion in 2025 and is set to expand at a CAGR of over 11.4%, surpassing USD 10.21 billion revenue by 2035.
North America is forecast to command 40% share by 2035 in the hematopoietic stem cells transplantation market, attributed to the presence of major key players and rising mergers and acquisitions fostering advanced treatment development.
Key players in the market include Duraflame Inc., Timber Charcoal Company Co. LLC, Gryfskand sp. z o.o, Kingsford Products Company, Royal Oak Enterprises, LLC, Weber-Stephen Products LLC, Snesmi Techno Pvt Ltd, Sun Company, Halogen Supply Co. Inc., Vale S.A.
